Questions? Call 800-624-6242
add to cart
Rights & Permissions
. "Appendix A: Workshop Agenda." Addressing the Barriers to Pediatric Drug Development: Workshop Summary. Washington, DC: The National Academies Press, 2008.
Please select a format:
The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Could Vaccines Be a Possible Model for Pediatric Drug Development?
Walter Orenstein, MD
Vaccine Adverse Event Reporting System
Current Models and Alternative Approaches
European Union Legislation
Annic Weyersberg, MD
European Agency for the Evaluation of Medicinal Products
St. Jude’s Approach to Addressing the Institute of Medicine Report: Making Better Drugs for Children with Cancer
William Evans, PharmD
St. Jude Children’s Research Hospital
Identification of Actions
Conclusions and Next Steps for the Institute of Medicine Drug Forum